Importance of dose-schedule of 5-aza-2'-deoxycytidine for epigenetic therapy of cancer von Lemaire, Maryse, Chabot, Guy G, Raynal, Noël Jm, Momparler, Louise F, Hurtubise, Annie, Bernstein, Mark L, Momparler, Richard L

Volltext

Preclinical evaluation of the antineoplastic action of 5-aza-2'-deoxycytidine and different histone deacetylase inhibitors on human Ewing's sarcoma cells von Hurtubise, Annie, Bernstein, Mark L, Momparler, Richard L

Volltext

Antineoplastic action of 5-aza-2′-deoxycytidine and phenylbutyrate on human lung carcinoma cells von Boivin, Anne-Julie, Momparler, Louise F, Hurtubise, Annie, Momparler, Richard L

Volltext

Effect of histone deacetylase inhibitor LAQ824 on antineoplastic action of 5-Aza-2'-deoxycytidine (decitabine) on human breast carcinoma cells von HURTUBISE, Annie, MOMPARLER, Richard L

Volltext

Evaluation of antineoplastic action of 5-aza-2′-deoxycytidine (Dacogen) and docetaxel (Taxotere) on human breast, lung and prostate carcinoma cell lines von Hurtubise, Annie, Momparler, Richard L

Volltext

Interaction of 5-aza-2′-deoxycytidine and depsipeptide on antineoplastic activity and activation of 14-3-3σ, E-cadherin and tissue inhibitor of metalloproteinase 3 expression in hu... von Gagnon, Jacynthe, Shaker, Sepideh, Primeau, Mélanie, Hurtubise, Annie, Momparler, Richard L

Volltext

Abstract LB-171: A phase 1 dose escalation study of BBI608, a first-in-class cancer stem cell pathway inhibitor in patients with advanced malignancies von Langleben, Adrian, Supko, Jeffrey G., Hotte, Sebastien, Lorusso, Patricia, Miller, Wilson H., Hurtubise, Annie, Leggett, David S., Li, Wei, Borodyanski, Laura, Li, Chiang J.

Volltext

Interaction of 5-aza-2'-deoxycytidine and depsipeptide on antineoplastic activity and activation of 14-3-3sigma, E-cadherin and tissue inhibitor of metalloproteinase 3 expression i... von Gagnon, Jacynthe, Shaker, Sepideh, Primeau, Mélanie, Hurtubise, Annie, Momparler, Richard L

Volltext